Table 2.
ICD-10 | Age | OR [CI] | p-value | Diagnosis rate (%) in patients with obesity |
---|---|---|---|---|
F17 Nicotine use |
10–19 | 4.95 [4.34–5.64] | <0.01 | 3.98 |
20–29 | 5.58 [5.21–5.97] | 10.99 | ||
30–39 | 5.45 [5.19–5.72] | 13.01 | ||
40–49 | 4.88 [4.72–5.04] | 16.87 | ||
50–59 | 3.61 [3.50–3.72] | 16.71 | ||
60–69 | 2.79 [2.69–2.90] | 11.9 | ||
70–79 | 2.62 [2.46–2.79] | 6.14 | ||
F20 Schizophrenia |
20–29 | 1.88 [1.62–2.17] | <0.01 | 1.7 |
30–39 | 1.84 [1.62–2.09] | 1.6 | ||
40–49 | 1.75 [1.56–1.96] | 1.27 | ||
50–59 | 1.53 [1.36–1.73] | 0.84 | ||
60–69 | 1.60 [1.39–1.84] | 0.72 | ||
F25 Schizoaffective dis. |
20–29 | 3.39 [2.77–4.15] | 0.95 | |
30–39 | 3.01 [2.58–3.51] | 1.04 | ||
40–49 | 2.86 [2.52–3.25] | <0.01 | 1 | |
50–59 | 2.59 [2.25–2.98] | 0.66 | ||
60–69 | 2.02 [1.65–2.47] | 0.43 | ||
F31 Bipolar dis. |
10–19 | <100 patients | 0.45 | |
20–29 | 0.83 | |||
30–39 | 1.63 [1.37–1.93] | <0.01 | 1 | |
40–49 | 1.65 [1.45–1.88] | 1.04 | ||
50–59 | 1.59 [1.39–1.81] | 0.78 | ||
60–69 | 2.01 [1.72–2.35] | 0.64 | ||
70–79 | <100 patients | 0.32 | ||
F32 Depressive episode |
10–19 | 2.13 [1.89–2.40] | <0.01 | 4 |
20–29 | 1.61 [1.46–1.78] | 5.78 | ||
30–39 | 1.96 [1.84–2.09] | 7.75 | ||
40–49 | 2.10 [2.01–2.20] | 10 | ||
50–59 | 2.35 [2.26–2.43] | 11.44 | ||
60–69 | 2.19 [2.10–2.28] | 10.56 | ||
70–79 | 2.04 [1.95–2.13] | 12.06 | ||
F33 Recurrent depression |
10–19 | <100 patients | 1.27 | |
20–29 | 2.24 [1.96–2.56] | <0.01 | 3.12 | |
30–39 | 2.02 [1.84–2.21] | 3.63 | ||
40–49 | 1.82 [1.70–1.94] | 4.62 | ||
50–59 | 1.85 [1.74–1.96] | 4.18 | ||
60–69 | 1.88 [1.74–2.04] | 2.95 | ||
70–79 | 1.83 [1.67–2.01] | 3.03 | ||
F34 Dysthymia |
20–29 | <100 patients | 0.44 | |
30–39 | 0.46 | |||
40–49 | 1.94 [1.62–2.31] | <0.01 | 0.73 | |
50–59 | 2.18 [1.89–2.52] | 0.81 | ||
60–69 | 2.39 [2.06–2.78] | 0.82 | ||
70–79 | 2.00 [1.68–2.37] | 0.9 | ||
F41 Anxiety dis. |
10–19 | 1.93 [1.59–2.35] | <0.01 | 1.53 |
20–29 | 1.75 [1.52–2.02] | 2.29 | ||
30–39 | 1.84 [1.67–2.03] | 3.48 | ||
40–49 | 1.97 [1.82–2.12] | 3.59 | ||
50–59 | 1.97 [1.83–2.12] | 3 | ||
60–69 | 2.16 [1.98–2.36] | 2.3 | ||
70–79 | 1.97 [1.76–2.21] | 2.01 | ||
F45 Somatization dis. |
10–19 | 2.04 [1.74–2.40] | <0.01 | 2.36 |
30–39 | 1.53 [1.32–1.77] | 1.66 | ||
40–49 | 1.88 [1.71–2.07] | 2.41 | ||
50–59 | 1.78 [1.62–1.95] | 1.84 | ||
60–69 | 1.78 [1.56–2.03] | 1.19 | ||
70–79 | 1.90 [1.61–2.25] | 1.09 | ||
F50 Eating dis. |
10–19 | 2.24 [1.89–2.65] | <0.01 | 1.89 |
20–29 | 1.98 [1.65–2.37] | 1.65 | ||
30–39 | 2.81 [2.32–3.40] | 0.97 | ||
40–49 | 4.89 [4.13–5.80] | 0.62 | ||
50–59 | <100 patients | 0.31 | ||
60–69 | 0.13 | |||
F60 Personality dis. |
10–19 | 2.71 [2.34–3.14] | <0.01 | 2.73 |
20–29 | 2.18 [1.95–2.42] | 4.27 | ||
30–39 | 1.89 [1.69–2.12] | 2.42 | ||
40–49 | 1.50 [1.33–1.70] | 1.31 | ||
60–69 | <100 patients | 0.21 |
All listed associations remained significant after correction for multiple testing. Diagnoses that were present in fewer than 100 patients with obesity within a specific age decade were not analyzed.